Omentum, BGU-hiPS, BGU-iPSCs	
    			    			
                BGUi013-A            
            
        General
Cell Line | 
					|
| hPSCreg name | BGUi013-A | 
| Cite as: | BGUi013-A (RRID:CVCL_A4YM) | 
| Alternative name(s) | 
									 
	Omentum, BGU-hiPS, BGU-iPSCs	 
							 | 
						
| Cell line type | Human induced pluripotent stem cell (hiPSC) | 
| Similar lines | No similar lines found. | 
| Last update | 27th April 2022 | 
| User feedback | |
Provider | 
					|
| Generator | Ben Gurion University of the Negev (BGU) | 
| Owner | Ben Gurion University of the Negev (BGU) | 
| Distributors | |
| Derivation country | Israel | 
External Databases | 
						|
| BioSamples | SAMEA8093240 | 
| Cellosaurus | CVCL_A4YM | 
| Wikidata | Q107113460 | 
							    
							General Information | 
					|
| Publications | |
| Projects | |
| * Is the cell line readily obtainable for third parties? | 
                                     Yes                                                                                 Research use: allowed 
                                                                                    Clinical use: not allowed 
                                                                                    Commercial use: not allowed 
                                                                         | 
                            
Donor Information
General Donor Information | 
					|
| Sex | female | 
Phenotype and Disease related information (Donor) | 
					|
| Diseases | No disease was diagnosed.
																	 | 
					
Karyotyping (Donor) | 
						|
| Has the donor karyotype been analysed? | 
								 Unknown 								
															 | 
						
External Databases (Donor) | 
						|
| BioSamples | SAMEA8152187 | 
Ethics
| Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? | Yes | 
| Was the consent voluntarily given? | Yes | 
| Has the donor been informed that participation will not directly influence their personal treatment? | Yes | 
| Can you provide us with a copy of the Donor Information Sheet provided to the donor? | No | 
| Do you (Depositor/Provider) hold the original Donor Consent Form? | No | 
| If you do not hold the Donor Consent Form, do you know who does? | Yes | 
| Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. | anonymised | 
| Does consent explicitly allow the derivation of pluripotent stem cells? | Yes | 
| Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? | No | 
Does consent permit research by | |
| an academic institution? | Yes | 
| a public organisation? | Yes | 
| a non-profit company? | Yes | 
| a for-profit corporation? | No | 
| How may genetic information associated with the cell line be accessed? | No information | 
| Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? | No | 
| Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | No | 
| Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? | No | 
| Is there an MTA available for the cell line? | No | 
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? | AddGene | 
| Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above? | No | 
hIPSC Derivation
General | 
						|
| Source cell type | 
										
				
	
			 The tissue that lines the wall of the abdominal cavity, intestine, mesentery, and pelvic organs. It consists of the parietal peritoneum and the visceral peritoneum. 
	
			Synonyms 
		
  | 
							
Reprogramming method | 
						|
| Vector type | Integrating | 
| Vector | Virus (Lentivirus) | 
| Is the used vector excisable? | 
										 Yes 									 | 
								
| Absence of reprogramming vector(s)? | 
										 Yes 									 | 
								
| Reprogramming vectors silenced? | 
										 Unknown 									 | 
								
Vector free reprogramming | 
						|
Other | 
						|
| Derived under xeno-free conditions | 
								 Unknown 							 | 
						
| Derived under GMP? | 
								 Unknown 							 | 
						
| Available as clinical grade? | 
								 Unknown 							 | 
						
Culture Conditions
| Medium | 
								Other medium:		 
			Base medium: NutriStem			 
				
		
								Main protein source: Serum concentration: %  | 
						
Characterisation
Analysis of Undifferentiated Cells
Differentiation Potency
In vitro spontaneous differentiation
					| Marker | Expressed | 
| AFP | 
										 Yes 					                 | 
								
In vitro spontaneous differentiation
					| Marker | Expressed | 
| ACTA2 | 
										 Yes 					                 | 
								
Morphology
In vitro spontaneous differentiation
					| Marker | Expressed | 
| NEFL | 
										 Yes 					                 | 
								
Morphology
Genotyping
Karyotyping (Cell Line) | 
					|
| Has the cell line karyotype been analysed? | 
								 Yes 								
																	
												normal
											 
																				
																																									
											Karyotyping method:
											G-Banding											
																						 
																			 | 
						
Other Genotyping (Cell Line) | 
					|


Login to share your feedback, experiences or results with the research community.